Bortezomid in association therapy in relapsed, refractory multiple myeloma: Experience of a single center

被引：0
|
作者：
Buquicchio, C. [1 ]
Iacobazzi, A. [1 ]
Tarantini, G. [1 ]
Ciuffreda, L. [1 ]
Desantis, G. [1 ]
Santorsola, D. [1 ]
Riezzo, A. [1 ]
机构：
[1] ASL Bat, UO Ematol, Trani, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [41] A Single-Center Experience on the Safety and Efficacy of Venetoclax-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma
    Zolotov, Eli
    Patel, Vanisha
    Weiss, Yedidyah
    Biran, Noa
    Phull, Pooja
    Vesole, David H.
    Siegel, David S.
    Parmar, Harsh
    BLOOD, 2024, 144 : 6959 - 6960
  • [42] Safety and Efficacy of Standard of Care (SOC) Elranatamab in Patients with Relapsed/Refractory Multiple Myeloma (RRMM), a Single Center Experience
    Grajales-Cruz, Ariel F.
    Hansen, Doris K.
    Castaneda, Omar
    Graeter, Allison
    Vazquez-Martinez, Mariola A.
    Modukuri, Shrikar
    De Avila, Gabriel
    Denson, Ariel
    Fadul, Julia
    Blue, Brandon
    Lopez, Blanca
    Harvey, Kristy
    Thapa, Shrinjaya B.
    Tobon, Katherine
    Melnick, Parker
    Ionescu, Filip
    Liu, Hien
    Ochoa-Bayona, Jose L.
    Freeman, Ciara Louise
    Locke, Frederick
    Nishihori, Taiga
    Shain, Kenneth H.
    Alsina, Melissa
    Baz, Rachid
    BLOOD, 2024, 144 : 7832 - 7833
  • [43] Subsequent anti-myeloma therapy after idecabtagene vicleucel treatment in patients with relapsed/refractory multiple myeloma: A single center analysis
    Parrondo, Ricardo D.
    Sam, Keren
    Rasheed, Ahsan
    Alegria, Victoria
    Sher, Taimur
    Roy, Vivek
    Chanan-Khan, Asher
    Ailawadhi, Sikander
    BLOOD CANCER JOURNAL, 2022, 12 (04)
  • [44] VENETOCLAX AS TARGETED THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Kumar, S.
    Kaufman, J. L.
    Mikhael, J.
    Gasparetto, C.
    Vij, R.
    Pegourie, B.
    Benboubker, L.
    Facon, T.
    Moreau, P.
    Amiot, M.
    Alzate, S.
    Dunbar, M.
    Xu, T.
    Agarwal, S.
    Leverson, J.
    Ross, J.
    Maciag, P.
    Verdugo, M.
    Touzeau, C.
    HAEMATOLOGICA, 2017, 102 : 268 - 269
  • [45] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, M.
    Truger, M.
    Bittrich, M.
    Zhou, X.
    Noderer, J.
    Riedhammer, C.
    Xiao, X.
    Gawlas, S.
    Philipp, W.
    Eisele, F.
    Haferlach, C.
    Mersi, J.
    Waldschmidt, J.
    Einsele, H.
    Rasche, L.
    Kortuem, K. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 58 - 58
  • [46] Venetoclax salvage therapy in relapsed/refractory multiple myeloma
    Steinhardt, Maximilian J.
    Truger, Marietta
    Bittrich, Max
    Zhou, Xiang
    Noderer, Julia
    Riedhammer, Christine
    Xiao, Xianghui
    Gawlas, Sophia
    Weis, Philipp
    Eisele, Florian
    Haferlach, Claudia
    Mersi, Julia
    Waldschmidt, Johannes
    Einsele, Hermann
    Rasche, Leo
    Kortuem, K. Martin
    HAEMATOLOGICA, 2024, 109 (03) : 979 - 981
  • [47] LENALIDOMIDE THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Okada, K.
    Okamoto, Y.
    Tsukamoto, T.
    Sugiura, H.
    Matsui, H.
    Ueda, T.
    Jo, T.
    Onishi, T.
    Kunitomi, A.
    Ueda, Y.
    ANNALS OF ONCOLOGY, 2013, 24
  • [48] NK cell therapy in relapsed refractory multiple myeloma
    Roshandel, Elham
    Ghaffari-Nazari, Haniyeh
    Mohammadian, Mozhdeh
    Salimi, Maryam
    Abroun, Saeid
    Mirfakhraie, Reza
    Hajifathali, Abbas
    CLINICAL IMMUNOLOGY, 2023, 246
  • [49] Bendamustine therapy for advanced relapsed/refractory multiple myeloma
    Shkury, Eden
    Geva, Mika
    Avigdor, Abraham
    Nevo, Lee
    Magen, Hila
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S189 - S189
  • [50] Venetoclax as Targeted Therapy for Relapsed/Refractory Multiple Myeloma
    Kumar, S.
    Kaufman, J. L.
    Mikhael, J.
    Gasparetto, C.
    Vij, R.
    Pegourie, B.
    Benboubker, L.
    Facon, T.
    Moreau, P.
    Amiot, M.
    Alzate, S.
    Dunbar, M.
    Xu, T.
    Agarwal, S.
    Leverson, J.
    Ross, J.
    Maciag, P.
    Verdugo, M.
    Touzeau, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 100 - 101
12345